OptimizeRx Q2 rev up 55% YoY to $29.2mln, raises FY25 guidance.

• OptimizeRx Q2 revenue $29.2mln, up 55% YoY • Q2 gross profit $18.6mln, up 59% YoY • Paid $4.5mln principal on term loan during Q2 • Full-year 2025 guidance: $104-$108mln revenue, $14.5-$17.5mln adjusted EBITDA

OptimizeRx Corp (OPRX) reported robust financial results for the second quarter of 2025, marking a significant increase in revenue and gross profit. The Waltham, Massachusetts-based company reported a 55% year-over-year (YoY) increase in revenue to $29.2 million, compared to $18.81 million in the same period last year [1]. This strong performance was driven by a 59% YoY increase in gross profit to $18.6 million.

During the quarter, OptimizeRx Corp also paid $4.5 million in principal on its term loan, indicating a commitment to managing its debt obligations. The company has provided full-year 2025 guidance, with revenue expected to range between $104 million and $108 million, and adjusted EBITDA projected to be between $14.5 million and $17.5 million.

Analysts expect OptimizeRx Corp to post earnings of 2 cents per share for the quarter ending June 30, 2025, with a mean revenue estimate of $22.264 million, up 18.4% from the same period last year [1]. The current average analyst rating on the shares is "buy," with a breakdown of recommendations including 6 "strong buy" or "buy," 1 "hold," and no "sell" or "strong sell."

OptimizeRx Corp's performance highlights its ability to drive growth and maintain profitability, positioning it favorably in the market. The company's focus on innovation and strategic acquisitions, as seen in its market strategy of buying top 500 stocks by volume, has contributed to its success. However, the stock has experienced a decline in share price, falling 9.93% despite a 5% adjusted EBITDA rise and a 37.8% margin expansion from asset disposals and operating leverage [2]. This discrepancy underscores the importance of understanding both financial performance and market sentiment when evaluating investment opportunities.

References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TX3XC:0-optimizerx-corp-expected-to-post-earnings-of-2-cents-a-share-earnings-preview/
[2] https://www.ainvest.com/news/thomson-reuters-q2-revenue-rises-3-162-surge-trading-volume-shares-drop-9-93-131st-market-activity-rank-2508/